PD-L1, PD-L2 peptides with Montanide ISA51
CLL19H1
Phase 2 other completed
Quick answer
PD-L1, PD-L2 peptides with Montanide ISA51 for Chronic Lymphocytic Leukemia is a Phase 2 program (other) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Chronic Lymphocytic Leukemia
- Phase
- Phase 2
- Modality
- other
- Status
- completed